Alzheimer's Disease -

Alzheimer's Disease

Clinical and Treatment Perspectives
Buch | Hardcover
198 Seiten
1994
John Wiley & Sons Ltd (Verlag)
978-0-471-95039-4 (ISBN)
220,74 inkl. MwSt
  • Titel ist leider vergriffen;
    keine Neuauflage
  • Artikel merken
Designed to update the reader on crucial aspects of research into Alzheimer's disease, this study discusses viable neurotransmitter treatment approaches and describes an innovative method of determining the proper dosage to use in clinical drug trials.
Progress in the basic and clinical research of Alzheimer's disease has been substantial in recent years and has contributed significantly to our understanding of the pathology which underlies the disease process. Although there has been no treatment breakthrough, advances in neuroscience research have provided a clearer focus for the clinical development of promising therapeutic strategies. Presented here is a comprehensive and authoritative account of the latest discoveries on Alzheimer's disease. Crucial areas of basic research are discussed as well as viable neurotransmitter treatment approaches and a method for determining the proper dose to use in clinical drug trials. Written by an international group of authors, the book will be of value to all researchers in Alzheimer's disease and to neuroscientists, neurologists and psychiatrists.

The Diagnosis of Alzheimer's Disease (C. Gottfries, et al.). Biochemical Aspects and CSF Markers in Alzheimer's Disease (K. Blennow, et al.). Brain Imaging and Alzheimer's Disease (Ph. Scheltens). The Cholinergic Hypothesis in Alzheimer's DiseaseClinical Evidence Gained with Velnacrine (K. Siegfried). Gangliosides Selectively Diminished in Early-Onset Alzheimer's Disease (AD Type 1) Suggest Synapse Loss as Primary Event (L. Svennerholm, et al.). Alzheimer's Disease: Is the Improvement of Cholinergic Transmission the Correct Strategy? (D. Bowen, et al.). -Amyloid, Cytokines and Other Potential Strategies for Modifying Pathophysiology of Alzheimer's Disease (C. Wilmot, et al.). Multiple Neurotransmitter Strategies for Treatment of Alzheimer's Disease (F. Huff). The Use of Bridging Studies in Drug Development for Alzheimer's Disease Therapeutics (N. Cutler, et al.). Index.

Erscheint lt. Verlag 22.11.1994
Zusatzinfo illustrations
Verlagsort Chichester
Sprache englisch
Maße 155 x 235 mm
Gewicht 500 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Geriatrie
Medizin / Pharmazie Medizinische Fachgebiete Neurologie
Medizin / Pharmazie Medizinische Fachgebiete Pharmakologie / Pharmakotherapie
ISBN-10 0-471-95039-4 / 0471950394
ISBN-13 978-0-471-95039-4 / 9780471950394
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Gisela Mötzing; Susanna Schwarz

Buch | Softcover (2022)
Urban & Fischer in Elsevier (Verlag)
33,00
das gesamte Spektrum der Altersmedizin für Klinik und Praxis

von Jürgen M. Bauer; Clemens Becker; Michael Denkinger

Buch | Hardcover (2024)
Kohlhammer (Verlag)
189,00
Das Wichtigste für Ärztinnen und Ärzte aller Fachrichtungen

von Klaus Hager; Olaf Krause

Buch | Softcover (2021)
Urban & Fischer in Elsevier (Verlag)
37,00